Stock NEULANDLAB NEULAND LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Neuland Laboratories Limited NSE India S.E.

Equities

NEULANDLAB

INE794A01010

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:48 2024-04-26 am EDT 		5-day change 1st Jan Change
6,973 INR -1.67% Intraday chart for Neuland Laboratories Limited -5.36% +31.79%
Apr. 12 INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes RE
Mar. 31 Neuland Laboratories Limited Announces Resignation of P.V. Maiya as Director CI

Business Summary

Neuland Laboratories Limited is an India-based company, which is engaged in manufacturing and selling of bulk drugs. The Company caters to both domestic and international markets. It manufactures active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The Company provide solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company operates through a single segment, manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services.

Number of employees: 1,554

Sales per Business

INR in Million2022Weight2023Weight Delta
Active Pharmaceutical Ingredients
93.7 %
8,874 93.3 % 11,156 93.7 % +25.72%
Services
3.8 %
360 3.8 % 453 3.8 % +25.95%
Export Incentives
1.3 %
166 1.7 % 154 1.3 % -7.23%
Scrap
1.1 %
92 1.0 % 131 1.1 % +43.19%
Impurities
0.1 %
20 0.2 % 18 0.1 % -10.20%

Sales per region

INR in Million2022Weight2023Weight Delta
North America
31.4 %
2,534 27.4 % 3,647 31.4 % +43.93%
Europe
31.0 %
2,682 29.0 % 3,595 31.0 % +34.06%
India
25.1 %
2,391 25.9 % 2,918 25.1 % +22.04%
Rest of the World
12.5 %
1,627 17.6 % 1,449 12.5 % -10.93%

Managers

Managers TitleAgeSince
Davuluri Sucheth Rao CEO
 Chief Executive Officer 48 01-12-31
Abhijit Majumdar DFI
 Director of Finance/CFO - 22-11-22
Sharadsrikar V. Kotturi CTO
 Chief Tech/Sci/R&D Officer - Nov. 21
Sarada Bhamidipati CMP
 Compliance Officer - 12-01-02
Davuluri Saharsh Rao BRD
 Director/Board Member 44 07-02-28

Members of the board

Members of the board TitleAgeSince
Prasad Raghava Menon BRD
 Director/Board Member 78 22-10-30
Homi Rustum Khusrokhan BRD
 Director/Board Member 80 19-02-11
Sugata Sircar BRD
 Director/Board Member 60 23-06-26
Davuluri Sucheth Rao CEO
 Chief Executive Officer 48 01-12-31
Davuluri Rama Mohan Rao FOU
 Founder 80 84-01-06
Cristopher Cimarusti BRD
 Director/Board Member 80 09-10-19
Bharati Manohar Rao BRD
 Director/Board Member 74 14-05-08
Davuluri Saharsh Rao BRD
 Director/Board Member 44 07-02-28
Pallavi Joshi Bakhru BRD
 Director/Board Member 55 23-06-26
Nirmala Murthy BRD
 Director/Board Member 77 15-05-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,900,500 8,172,615 ( 63.35 %) 0 63.35 %

Shareholders

NameEquities%Valuation
Davuluri Rama Mohan Rao
21.59 %
2,769,974 21.59 % 209 M ₹
Malabar Investments LLC
12.64 %
1,621,782 12.64 % 122 M ₹
Davuluri Vijaya Rao
4.781 %
613,338 4.781 % 46 M ₹
Matthews International Capital Management LLC
4.071 %
522,353 4.071 % 39 M ₹
Mukul Mahavir Agrawal
3.118 %
400,000 3.118 % 30 M ₹
Davuluri Sucheth Rao
2.631 %
337,542 2.631 % 25 M ₹
HSBC Asset Management (India) Pvt Ltd.
2.596 %
333,002 2.596 % 25 M ₹
Davuluri Saharsh Rao
2.238 %
287,087 2.238 % 22 M ₹
quant Money Managers Ltd.
1.497 %
192,067 1.497 % 14 M ₹
Ocean Dial Asset Management Ltd.
1.332 %
170,888 1.332 % 13 M ₹

Company contact information

Neuland Laboratories Ltd.

Phoenix IVY Building Plot No.573A-III, Road No. 82

500033, Hyderabad

+91 40 6761 1600

http://www.neulandlabs.com
address Neuland Laboratories Limited(NEULANDLAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Neuland Laboratories Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6,984 INR
Average target price
8,300 INR
Spread / Average Target
+18.85%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NEULANDLAB Stock
  4. NEULANDLAB Stock
  5. Company Neuland Laboratories Limited